CD34+ selection of hematopoietic blood cell collections and autotransplantation in lymphoma: overnight storage of cells at 4°C does not affect outcome
Tóm tắt
Từ khóa
Tài liệu tham khảo
Schmitz N, Linch DC, Dreger P et al. Randomised trial of filgrastim-mobilised peripheral blood progenitor cell transplantation versus autologous bone-marrow transplantation in lymphoma patients Lancet 1996 347: 353–357
Léonard BM, Hétu F, Busque L et al. Lymphoma cell burden in progenitor cell grafts measured by competitive polymerase chain reaction: less than one log difference between bone marrow and peripheral blood sources Blood 1998 91: 331–339
Ross AA, Cooper BW, Lazarus HM et al. Detection and viability of tumor cells in peripheral blood stem cell collections from breast cancer patients using immunocytochemical and clonogenic assay techniques Blood 1993 82: 2605–2610
Sharp JG, Kessinger A, Mann S et al. Outcome of high-dose therapy and autologous transplantation in non-Hodgkin's lymphoma based on the presence of tumor in the marrow or infused hematopoietic harvest J Clin Oncol 1996 14: 214–221
Brenner MK, Rill DR, Moen RC et al. Gene-marking to trace origin of relapse after autologous bone-marrow transplantation Lancet 1993 341: 85–86
Negrin RS, Kusnierz-Glaz CR, Still BJ et al. Transplantation of enriched and purged peripheral blood progenitor cells from a single apheresis product in patients with non-Hodgkin's lymphoma Blood 1995 85: 3334–3341
Gribben JG, Neuberg D, Freeman AS et al. Detection by polymerase chain reaction of residual cells with the bcl-2 translocation is associated with increased risk of relapse after autologous bone marrow transplantation for B cell lymphoma Blood 1993 81: 3449–3457
Deisseroth A, Zu Z, Claxton D et al. Genetic marking shows that Ph+ cells present in autologous transplants of chronic myelogenous leukemia (CML) contribute to relapse after autologous bone marrow in CML Blood 1994 83: 3068–3076
Moolten DN . Peripheral blood stem cell transplant: future directions Semin Oncol 1995 22: 271–290
Demirer T, Gooley T, Buckner CD et al. Influence of total nucleated cell dose from marrow harvests on outcome in patients with acute myelogenous leukemia undergoing autologous transplantation Bone Marrow Transplant 1995 15: 907–913
Rizzi S, Motta MR, Fortuna M et al. Positive selection and transplantation of autologous hematopoietic CD34+ cells after myeloblative therapy. Twenty First Annual Meeting of EBMT Davos, Switzerland, 1995.
Stewart AK, Vescio R, Schiller G et al. Phase III study evaluating CD34 selected versus unselected autologous peripheral blood progenitor cell transplantation in 190 patients with advanced multiple myeloma Blood 1998 92: (Suppl. 1) 662a
Franklin W, Shpall E, Archer P et al. Immunocytochemical detection of breast cancer cells in marrow and peripheral blood of patients undergoing high dose chemotherapy with autologous stem cell support Breast Cancer Res 1996 41: 1–13
Gorin NC, Lopez M, Laporte JP et al. Preparation and successful engraftment of purified CD34+ bone marrow progenitor cells in patients with non-Hodgkin's lymphoma Blood 1995 85: 1647–1654
Holland HK, Fleming WH, Waller EK et al. Selection and transplantation of autologous CD34+ peripheral blood stem cells in non-Hodgkin's lymphoma using high-speed fluorescence-activated cell sorting Blood 1998 88: (Suppl. 1) 407a
Gribben JG, Freedman AS, Neuberg D et al. Immunologic purging of marrow assessed by PCR before autologous bone marrow transplantation for B-cell lymphoma New Engl J Med 1991 325: 1525–1533
Koç ON, Gerson SL, Phillips GL et al. Autologous CD34+ cell transplantation for patients with advanced lymphoma: effects of overnight storage on peripheral blood progenitor cell enrichment and engraftment Bone Marrow Transplant 1998 21: 337–343
A predictive model for aggressive non-Hodgkin's lymphoma . The International Non-Hodgkin's Lymphoma Prognostic Factors Project New Engl J Med 1993 329: 987–994
Bender JG, Unverzagt K, Walker D . Guidelines for determination of CD34+ cells by flow cytometry: application to the harvesting and transplantation of peripheral blood stem cells. In: Wunder E, Sovalat H, Hénon P, Serke S (eds) Hematopoietic Stem Cells. The Mulhouse Manual AlphaMed Press: Dayton, OH 1994 pp 31–43
Lazarus HM, Crilley P, Ciobanu N et al. High-dose carmustine, etoposide, cisplatin (BEP) and autologous bone marrow transplantation for relapsed and refractory lymphoma J Clin Oncol 1992 10: 1682–1689
Gingrich RD, Ginder GD, Burns LJ et al. BVAC ablative chemotherapy followed by autologous bone marrow transplantation for patients with advanced lymphoma Blood 1990 75: 2276–2281
Mills W, Chopra R, McMillan A et al. BEAM chemotherapy and autologous bone marrow transplantation for patients with relapsed or refractory non-Hodgkin's lymphoma J Clin Oncol 1995 13: 588–595
Peto R, Pike MC, Armitage P et al. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Introduction and design Br J Cancer 1976 34: 585–612
Sharp JG, Joshi SS, Armitage JO et al. Significance of detection of occult non-Hodgkin's lymphoma in histologically uninvolved bone marrow by a culture technique Blood 1992 79: 1074–1080
Lazarus HM, Rowe JM, Goldstone AH . Does in vitro purging improve the outcome after autologous bone marrow transplantation? J Hematother 1994 2: 457–466
Beaujean F, Pico J, Norol F et al. Characteristics of peripheral blood progenitor cells frozen after 24 hours of liquid storage J Hematother 1996 5: 681–686
Pettengell R, Woll PJ, O'Connor DA et al. Viability of haemopoietic progenitors from whole blood, bone marrow and leukapheresis product: effects of storage media, temperature and time Bone Marrow Transplant 1994 14: 703–709
Hechler G, Weide R, Heymanns J et al. Storage of noncryopreserved peripheral blood stem cells for transplantation Ann Hematol 1996 72: 303–306
Jestice HK, Scott MA, Ager S et al. Liquid storage of peripheral blood progenitor cells for transplantation Bone Marrow Transplant 1994 14: 991–994
Lane TA, Young D, Mullen M et al. Effect of storage on engraftment of mobilized peripheral blood progenitor cells Blood 1997 90: (Suppl. 2) 329b
Sugrue MW, Hutcheson CE, Fisk DD et al. The effect of overnight storage of leukapheresis stem cell products on cell viability, recovery and cost J Hematother 1998 7: 431–436
Chabannon C, Moatti J-P, Maraninchi D . Will CD34+ standardization solve all problems related to cell therapy? (letter) J Hematother 1997 6: 439–440
Watts MJ, Sullivan AM, Leverett D et al. Back-up bone marrow is frequently ineffective in patients with poor peripheral-blood stem-cell mobilization J Clin Oncol 1998 16: 1554–1560
Weaver CH, Tauer K, Zhen B et al. Second attempts at mobilization of peripheral blood stem cells in patients with initial low CD34+ cell yields J Hematother 1998 7: 241–249
Moskowitz CH, Glassman JR, Wuest D et al. Factors affecting mobilization of peripheral blood progenitor cells in patients with lymphoma Clin Cancer Res 1998 4: 311–316
Brugger W, Bross KJ, Glatt M et al. Mobilization of tumor cells and hematopoietic progenitor cells into peripheral blood of patients with solid tumors Blood 1994 83: 623–640
Kahn DG, Prilutskaya M, Cooper B et al. The relationship between the incidence of tumor contamination and number of phereses for stage IV breast cancer Blood 1997 90: (Suppl. 1) 565a